Inclusion Criteria:  Adult women diagnosed with rheumatoid arthritis under pharmacological treatment, for at least 6 months, with a monoclonal antibody against the interleukin-6 receptor or TNF-alpha inhibitors; Stable dose of monoclonal antibody against the interleukin-6 receptor or TNF-alpha inhibitors in the previous 3 months;  Exclusion Criteria:  Any physical limitation or disability that preclude exercise participation; Participation in a structured exercise program in the previous 12 months;